-
'A very big deal': Canadian astronaut reflects on historic Moon mission
-
US pro table tennis league blasts niche sport into spotlight
-
Iran defiant as Trump threatens to destroy oil island
-
Trump threatens to destroy Iran oil island despite claims of talks
-
NASA begins countdown to April 1 Moon launch
-
NBA Bulls fire Ivey after anti-LGBTQ comments
-
Australian regulator probes Facebook, YouTube over teen social media ban
-
Iraq coach shielding players from war ahead of World Cup bid
-
Undav rescues Germany late in Ghana friendly
-
Messi to start for Argentina in World Cup send-off: Scaloni
-
Oil rises on Trump's Iran threats, stocks mixed
-
After pope's remark, White House defends praying for US troops
-
Powell probe leaves US Fed leadership change in limbo
-
Celine Dion announces comeback following health struggle
-
'Is it Kafka?' US judge baffled by new Pentagon press policy
-
Cubans ready for Russian oil but some say not enough
-
Teen Suryavanshi shines as Rajasthan hammer Chennai in IPL
-
Stock market winners and losers one month into US-Israel war on Iran
-
Hodgson says surprise return to management is only for short-term
-
What could Trump achieve by threatening Iran's Kharg Island?
-
India declares victory over Maoist insurgency
-
Germany's Merz pushes return of Syrians as he hosts leader Sharaa
-
G7 ministers pledge 'necessary measures' to ensure stable energy market
-
Cardiff City lose compensation case over Emiliano Sala death
-
Several French far-right mayors take down EU flags
-
Air Canada CEO to retire after row over English-only condolence message
-
Oil rises on Trump's Iran threats, stocks take cue on talks
-
Syrian leader pledges to work with Germany on migration, recovery
-
AI agent future is coming, OpenClaw creator tells AFP
-
Cardiff lose 122 mn euro compensation case over Emiliano Sala death
-
Tuchel defends Rice and Saka after England withdrawals
-
G7 ministers tackle economic fallout of Mideast war
-
Tottenham close in on De Zerbi as next boss - reports
-
Kenya's former NY marathon champion Korir gets 5-year doping ban
-
Lukaku says 'could never turn back on Napoli' after treatment row
-
Syrian leader visits Germany to talk war, recovery, refugees
-
Renault says developing ground-based military drone
-
Iran hangs two 'political prisoners' from banned opposition: activists
-
Russia expels UK diplomat on spying allegations
-
Premier League fans back call to scrap VAR
-
Italy hoping to scale World Cup 'Everest' ahead of Bosnia play-off showdown
-
Japan's cherry blossom season dazzles locals and tourists
-
EU ups mackerel quotas to match UK despite overfishing concerns
-
Crude rises, stocks drop as Houthi attacks escalate Iran war
-
Australian Rules player banned for wiping blood on face of opponent
-
Sheep culls put pressure on Greek feta cheese production
-
One man, his dog, and ChatGPT: Australia's AI vaccine saga
-
Israel PM restores access after Latin Patriarch blocked from Holy Sepulchre
-
Israel strikes Tehran as Trump says Iran deal may be reached 'soon'
-
Italy chase World Cup spot as Kosovo bid to make debut
US pharmacy chains announce abortion pill rollout
America's two biggest pharmacy chains said Friday they will begin dispensing prescription abortion pills in a limited number of states where it's legal.
The move greatly broadens availability of the drug mifepristone, even as a legal case over whether it was properly approved two decades ago now rests before the Supreme Court.
Walgreens "expects to begin dispensing within a week" in New York, Pennsylvania, Massachusetts, California, and Illinois, the company said on its website.
"But in the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing," it added.
A CVS spokesperson told AFP: "We'll begin filling prescriptions for the medication in Massachusetts and Rhode Island in the weeks ahead and will expand to additional states, where allowed by law, on a rolling basis."
The Food and Drug Administration (FDA) authorized pharmacies to carry mifepristone in January 2023, with Friday's announcements the results of a long certification process.
Mifepristone works to block a pregnancy, while a second drug, misoprostol, provokes bleeding to empty the uterus and was already widely available in pharmacies.
The news was hailed by President Joe Biden, who has made protecting reproductive rights a key part of his re-election campaign against the likely Republican candidate Donald Trump.
Trump tipped the balance of the Supreme Court during his own presidency and paved the way for reversal of the national right to abortion.
"With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy -- just as they would for any other medication," Biden said in a statement.
"The stakes could not be higher for women across America. In the face of relentless attacks on reproductive freedom by Republican elected officials, Vice President Harris and I will continue to fight to ensure that women can get the health care they need."
The US Supreme Court overturned the nationwide right to abortion in 2022, allowing each state to pass its own laws governing the procedure.
Twenty-one states have since banned or moved to restrict abortions to limits tighter than before Roe v Wade, the previous case that upheld the constitutional right to terminate a pregnancy.
Abortion pills remain illegal in states where the procedure is prohibited. But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic, reducing their travel.
The Supreme Court will hear arguments March 26 in a case brought by anti-abortion groups to restrict access to mifepristone, first approved in the year 2000 and used by more than 5.6 million Americans since.
O.Brown--AT